Exact Sciences Corp.’s recently made public that its President and CEO Conroy Kevin T unloaded Company’s shares for reported $0.49 million on Mar 01 ’24. In the deal valued at $59.32 per share,8,271 shares were sold. As a result of this transaction, Conroy Kevin T now holds 1,299,496 shares worth roughly $80.7 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, LEVANGIE DANIEL J sold 5,000 shares, generating $287,500 in total proceeds. Upon selling the shares at $57.50, the Director now owns 22,975 shares.
Before that, Cunningham Everett sold 2,412 shares. Exact Sciences Corp. shares valued at $143,080 were divested by the Chief Commercial Officer at a price of $59.32 per share. As a result of the transaction, Cunningham Everett now holds 46,179 shares, worth roughly $2.87 million.
The Benchmark Company upgraded its Exact Sciences Corp. [EXAS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wolfe Research began covering EXAS with “an Outperform” recommendation on December 13, 2023. Piper Sandler revised its rating on October 10, 2023. It rated EXAS as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of EXAS
On Friday, Exact Sciences Corp. [NASDAQ:EXAS] saw its stock jump 0.16% to $62.10. Over the last five days, the stock has gained 7.61%. Exact Sciences Corp. shares have fallen nearly -16.06% since the year began. Nevertheless, the stocks have fallen -3.23% over the past one year. While a 52-week high of $100.77 was reached on 01/02/24, a 52-week low of $56.05 was recorded on 02/28/24. SMA at 50 days reached $61.90, while 200 days put it at $73.21. A total of 1.01 million shares were traded, compared to the trading of 4.26 million shares in the previous session.
Levels Of Support And Resistance For EXAS Stock
The 24-hour chart illustrates a support level at 60.78, which if violated will result in even more drops to 59.45. On the upside, there is a resistance level at 62.90. A further resistance level may holdings at 63.69. The Relative Strength Index (RSI) on the 14-day chart is 54.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.07, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.10%. Stochastics %K at 72.28% indicates the stock is a holding.
How much short interest is there in Exact Sciences Corp.?
A steep rise in short interest was recorded in Exact Sciences Corp. stocks on Feb 29, 2024, dropping by -0.25 million shares to a total of 7.04 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 7.29 million shares. There was a decline of -3.55%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 3.91% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.04.
The most recent change occurred on September 28, 2023 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $83 price target.
